Literature DB >> 17960070

Relation between serum thyroid hormone and 'nondipper' circadian blood pressure variability.

Mehmet Kanbay1, Faruk Turgut, Feridun Karakurt, Bunyamin Isik, Rabia Alkan, Ali Akcay, Ramazan Yigitoglu, Adrian Covic.   

Abstract

Currently, the pathogenesis of nondipper hypertension remains largely unclear in patients without any renal or endocrine pathology. It is well known that overt hypothyroidism is strongly associated with diastolic hypertension. However, no study has addressed the pathogenic role of TSH, free T3 (FT3), and free T4 (FT4) in nondipper hypertension. The aim of the present investigation is to evaluate if higher TSH, low FT3 and FT4 would be associated with a nondipper hypertension profile, in patients with normal renal function and without any overt thyroid hormone disorder. 131 subjects were screened and those who met the following inclusion criteria were enrolled: (1) glomerular filtration rate (GFR) >60 ml/min; (2) no history of thyroid disorders; (3) no history of thyroid hormone medication. All subjects underwent 24-hour ambulatory blood pressure monitoring on a usual working day. Of the total population, 59 patients (45%) were classified as dippers and 72 (55%) were classified as nondippers. The only significant differences between dipper and nondipper patients appear to be related to FT3 levels and GFR. Nondipper patients had lower FT3 levels (4.5 +/- 0.6 vs. 4.0 +/- 0.9 pmol/l, p = 0.02) and low GFR (80.5 +/- 12.2 vs. 86.9 +/- 16.9 ml/min, p = 0.03), compared to dipper patients. The final regression model included serum TSH, FT3 levels, and GFR; the only independent predictor of nondipper hypertension was FT3 (p = 0.04). In conclusion, even if the mechanisms of our findings remain incompletely understood, we demonstrate a graded independent relation between lower level of FT3 and the risk of nondipping. Further studies are warranted to confirm this relationship and to elucidate the pathogenetic mechanisms of this relationship. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960070     DOI: 10.1159/000110082

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  4 in total

1.  Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism.

Authors:  Ismail Polat Canbolat; Erdal Belen; Akif Bayyigit; Aysen Helvaci; Kadriye Kilickesmez
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

2.  Evaluation of biochemical, hematological, and thyroid function parameters in nondipper and dipper hypertensive patients.

Authors:  Ibrahim Akpinar; Nurcan Basar; Nihat Sen; Halil Lutfu Kisacik
Journal:  Wien Klin Wochenschr       Date:  2012-07-06       Impact factor: 1.704

3.  Thyroid function and cardiovascular events in chronic kidney disease patients.

Authors:  Baris Afsar; Mahmut Ilker Yilmaz; Dimitrie Siriopol; Hilmi Umut Unal; Mutlu Saglam; Murat Karaman; Mustafa Gezer; Alper Sonmez; Tayfun Eyileten; Ibrahim Aydin; Salih Hamcan; Yusuf Oguz; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2016-04-02       Impact factor: 3.902

4.  The relationship between nocturnal blood pressure and hemorrhagic stroke in Chinese hypertensive patients.

Authors:  Jialan Sun; Wanlin Yang; Yang Zhu; Xiaohong Liu; Xin Wei; Baisong Wang; Jiuchang Zhong; Yi Fu
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-24       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.